focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Commercial R&D Partnership Service

8 Oct 2020 07:00

RNS Number : 4412B
Applied Graphene Materials PLC
08 October 2020
 

08 October 2020

 

Applied Graphene Materials plc

 

("Applied Graphene Materials", "AGM" or "the Group")

 

AGM launches unique Innovation Accelerator research and development partnership service

 

Applied Graphene Materials, the producer of speciality graphene nanoplatelet dispersions, has launched a new commercial service offering. 'Innovation Accelerator' is a unique end-to-end research and development service to support businesses in harnessing the potential of graphene in their products.

 

Through Innovation Accelerator, AGM's unique offering can support customers through to product launch with this end-to-end service. The programme offers customers a range of innovative solutions, from exclusive graphene enhanced dispersions tailored for their system, to working directly with AGM's technical experts to develop a customised project, formulation services and full system application testing and product characterisation.

 

Innovation Accelerator represents a potential new revenue stream for AGM and acknowledges its high-value support to customers during their product development phase, which can often last months. Partners will pay a one-off fee for a package to include research and development, quality control testing, on-going stability trials and a starter kit of a graphene dispersion. Tailored dispersions made to customers' product specifications are priced separately.

 

The Innovation Accelerator offering will be made available to existing commercial partners as well as to companies with whom AGM is not yet formally engaged, and will be actively marketed via AGM's distribution network which now spans the majority of Europe, North America, and Japan.

 

Adrian Potts, Chief Executive Officer of AGM, said:

 

"The exciting product launches of our customers in recent days and months have been the result of extensive testing and collaboration with AGM's outstanding technicians, who have developed unique proprietary IP in graphene dispersion and application. Without their ongoing support it would simply not have been possible for many of these ground-breaking, graphene-enhanced products to be brought to market so quickly, allowing our customers an early competitive advantage over their industry peers. I am confident that the formal launch of our Innovation Accelerator service will support growing momentum of product development both with AGM's existing and new customers across the world, and I would like to pay tribute to the great skill and hard work of our talented team."

 

 

For further information please contact:

 

Applied Graphene Materials

+44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer 

David Blain, Chief Financial Officer

 

N+1 Singer

+44 (0) 207 496 3000

Peter Steel / Amanda Gray

 

Hudson Sandler

 +44 (0) 207 796 4133

Charlie Jack / Emily Dillon

 

Notes to Editors:

 

Applied Graphene Materials - For the last decade, AGM has been at the forefront of harnessing the possibilities of graphene. Founded originally by Professor Karl Coleman, the Group has grown from an academic idea from Durham University to a world leader in the development and application of graphene nanoplatelet dispersions for customers in the coatings, composites and functional materials sectors.

 

The Group utilises its proprietary bottom-up manufacturing process to produce high purity graphene nanoplatelets. Their expertise in dispersion chemistry enables AGM to create optimised, stable and easy to handle dispersions that customers use in real-world industrial products. AGM's unique approach enables industries to fully realise the potential of graphene in a simple, safe and easy to formulate way.

 

AGM, based at the Wilton Centre on Teesside, was admitted to AIM in November 2013, raising £11 million. The Group successfully raised £8.5m in January 2016 and a further £9.8m in November 2017. Since August 2020, the Group's shares are also listed on OTCQX in the United States. As a result of the funding support and their industry leading technology platform, AGM have been able to develop a significant sales distribution network covering Europe, North America and a partner in Japan. The Group continues to work closely with industrial partners, and have seen the successful launch of numerous commercial products enhanced by their Graphene Dispersions.

https://www.appliedgraphenematerials.com/

 

 

Innovation Accelerator services include:

 

Customised Dispersion - AGM offers the development of customised graphene-based dispersion in the solvent or liquid resin system as specified by the customer. These are optimised, stable and easy to use dispersions and are exclusively available for the specific customer.

 

Customer Formulation Development - AGM chemists work directly with the customer's formulations, creating a series of optimised graphene containing options ready for development and product testing.

 

Customised Product Testing Programme - AGM can share the testing burden to help accelerate development and ensure the quick route to market for the new products.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAMRBMTMTAMTBM
Date   Source Headline
25th Apr 20187:00 amRNSIssue of share options to Directors
18th Apr 20188:41 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSInterim Results
8th Mar 20187:00 amRNSCollaboration with SHD and Magna Exteriors
1st Feb 20187:00 amRNSBoard Change
15th Jan 20189:22 amRNSHolding(s) in Company
10th Jan 20185:30 pmRNSHolding(s) in Company
10th Jan 20184:40 pmRNSSecond Price Monitoring Extn
10th Jan 20184:35 pmRNSPrice Monitoring Extension
8th Jan 20181:21 pmRNSHolding(s) in Company
4th Jan 20187:00 amRNSResult of AGM
3rd Jan 20187:00 amRNSAGM Statement
12th Dec 20177:00 amRNSNotice of AGM
7th Nov 20179:47 amRNSHolding(s) in Company
2nd Nov 20177:00 amRNSDirector/PDMR Shareholding
30th Oct 20171:15 pmRNSResults of Open Offer and General Meeting
12th Oct 20175:19 pmRNSPosting of Circular and Notice of General Meeting
10th Oct 20176:16 pmRNSFurther Details on the Fundraising
10th Oct 201711:41 amRNSClose of Accelerated Bookbuild
10th Oct 201711:00 amRNSPrice Monitoring Extension
10th Oct 20177:05 amRNSProposed Placing by Accelerated Bookbuild
10th Oct 20177:00 amRNSPreliminary Results
22nd Aug 20177:00 amRNSInvestor Site Visit
24th May 20177:00 amRNSNew Graphene Delivery Technology & Trading Update
22nd May 20174:18 pmRNSIssue of Equity and Total Voting Rights
26th Apr 20174:35 pmRNSPrice Monitoring Extension
11th Apr 20177:00 amRNSInterim Results
7th Apr 20174:40 pmRNSSecond Price Monitoring Extn
7th Apr 20174:35 pmRNSPrice Monitoring Extension
5th Apr 20174:40 pmRNSSecond Price Monitoring Extn
5th Apr 20174:35 pmRNSPrice Monitoring Extension
1st Feb 20177:00 amRNSGrant of Options
30th Jan 20177:00 amRNSShare Purchase by CFO-Designate
25th Jan 20177:00 amRNSBoard & Operational Appointments
20th Dec 20167:00 amRNSAGM Statement
31st Oct 20167:01 amRNSDirector/PDMR Shareholding
31st Oct 20167:00 amRNSDirectorate Change
17th Oct 20167:00 amRNSFinal Results
14th Oct 20167:00 amRNSFirst Production Order
12th Aug 20167:38 amRNSExercise of Share Options and PDMR Dealing
12th Aug 20167:00 amRNSDirectorate Change
12th Aug 20167:00 amRNSPeriod end trading update and notice of results
8th Aug 20167:00 amRNSProduct Development and New JDA
23rd Mar 20167:00 amRNSInterim Results
26th Jan 20163:21 pmRNSHolding(s) in Company
26th Jan 201612:15 pmRNSResult of AGM
25th Jan 20167:00 amRNSAGM Statement
22nd Jan 201610:33 amRNSHolding(s) in Company
13th Jan 20169:08 amRNSHolding(s) in Company
11th Jan 20163:42 pmRNSIssue of share options to Directors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.